Get started
Author

Raphaël Lattenist

Observed names: Lattenist, Raphaël, R. Lattenist, Raphael Lattenist
ORCID: 0000-0003-0383-9648
Observed ORCID: 0000-0003-0383-9648
OpenAlex ID: A5076750303
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
2020 · Abi Vijenthira, Inna Y. Gong, et al. · Blood · 630
PDF
COVID-19 in Adult Patients with Hematological Disease: Analysis of Clinical Characteristics and Outcomes
2020 · R. Lattenist, H. Yildiz, et al. · Indian Journal of Hematology and Blood Transfusion · 19
PDF
COVID-19 : infection par le virus SARS-CoV-2
2020 · Julien De Greef, Lucie Pothen, et al. · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · 4
Acquired hemophilia due to immune checkpoint inhibitors: a case series introducing emicizumab treatment
2025 · Louis Wolff, Carolin Ertl, et al. · The Oncologist · 2
PDF
Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients
2020 · Abi Vijenthira, Inna Gong, et al. · Blood · 1
PDF
Clinical Spectrum, Treatments and Outcomes of VEXAS Syndrome: A Multicenter Belgian Cohort
2026 · L. Funaro, L. Naesens, et al. · medRxiv
P-040: Unusual presentation of multiple myeloma with rapidly progressing lesions of the distal bones: about a case report
2022 · Raphaël Lattenist, Frédéric Lecouvet, et al. · Clinical Lymphoma Myeloma & Leukemia
Works count: 8
Citation count: 656
H-index: 3
I10-index: 2
Year
Topic
Type